Educational Qualification

• Postdoctoral Researcher, The University of West Indies, Trinidad (2006-2008) 
• Ph.D.:  Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (2006)
• M. Pharm.: (Pharmaceutical Chemistry), Karnatak University, Dharwad, India (1997)
• Bachelor of Pharmacy: RTM Nagpur University, Nagpur, India (1995)  

Professional Career

• Professor and Chairperson, Department of Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (June 2019 till date)  
• Chairperson in-charge, Department of Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (September 2017 to May 2019).  
• Associate Professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (June 2014 to May 2019)   
• Assistant professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (Nov 2010 to May 2014)  
• Lecturer in Pharmaceutical Chemistry, School of Pharmacy and Health Sciences, International Medical University, Kuala Lumpur, Malaysia (Aug 2008- Nov 2010) 
• Postdoctoral Researcher, Department of Chemistry, The University of West Indies, Trindad, (Nov 2006- June 2008)
• Assistant Professor, Institute of Pharmaceutical Education & Research, Wardha, India (Oct 2005-August 2006) 
• Lecturer in Pharmaceutical Chemistry, Anuradha College of Pharmacy, Chikhli, MS, India (Jan 1998-Jan 2001) 
• Senior Research Fellow, The Council of Scientific and Industrial Research (CSIR), Ministry of Science & Technology, Government of India at KLE College of Pharmacy, Belgaum, India (Jan 2002-04) 

Achievements/ Interests/Publications/Awards

Patents: 02; Review Reports/Articles: 03, Book Chapters: 02; Publications: 17; Conference presentations: 30

• Bhoomendra A. Bhongade, Sirajunisa Talath, Chiral imidazo[2,1-b][1,3,4]thiadiazole compounds and processes for synthesizing the same. Indian Patent 373257, July 29, 2021.
• G. Singh, P.J. Plaza, B. A. Bhongade. Synthesis and use of chiral ionic liquids. United States Patent, US8,788,689 B1, July 15, 2014.
• Venkataraman B, Ojha S, Belur PD, Bhongade, B, Raj V, Collin PD, Adrian TE, Subramanya SB. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases. Phytotherapy Research. 2020;1–20. 
• Afraz Subratti, Nigel K. Jalsa, Bhoomendra Bhongade. Chapter 25, Synthesis of 2,2,2-Trifluoroethyl Glucopyranoside and Mannopyranoside via Classical Fischer Glycosylation. In Kosma P, Wrodnigg TM, Stutz A editors, Carbohydrate Chemistry: Proven Synthetic Methods. Vol 5, Issue 1, CRC Press, Taylor & Francis; 2021, p. 199-206
• Dhote AM, Patil VR, Lokwani DK, Amnerkar ND, Ugale VG, Charbe NB, Bhongade BA, Khadse SC. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: In silico molecular docking and dynamic simulation studies. Journal of Biomolecular Structure and  Dynamics,  (2021, In press)  DOI: 10.1080/07391102.2021.1965912
• Venkataraman B, Almarzooqi S, Raj V, Dudeja PK, Bhongade BA, Patil RB, Ojha SK, Attoub S, Adrian TE, Subramanya SB. α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study. PPAR Res. 2022, 13;2022:5498115
• Ahmad I, Shagufta, Kim BS, Rahman S, Mathew S, Bhongade BA, Biomass derived adsorbent for the removal of methylene bule dye from wastewater. Indian J. Environmental Protection, 2021, 41(12),1323-1324.
• Alnaqbi AMS, Bhongade BA, AlAzzawi A. New Validated Diffuse Reflectance Infrared Fourier Transform Spectroscopic Methodor the Quantification of Levofloxacin in Pharmaceutical Dosage Form. Ind. J. Pharm. Sci., 2021, 83(3), 430-36
• Bhongade BA, Amnerkar ND, Gadad AK. 3D-QSAR Studies on 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as Plk-1, CDK2/A and Aur-A Serine/Threonine Kinase Inhibitors. Lett. Drug Des. Discov. 2020, 17(4), 386-393.

Awards:

• Senior Research Fellowship, Council of Scientific & Industrial Research (CSIR), New Delhi, India (2002-2005)
• Research Interests Chiral drug (intermediate) synthesis
• Computer aided-drug design, Molecular modelling, 3D-QSAR, Molecular docking.
• Design and synthesis of small molecule as selective inhibitors of enzyme targets involved cancer, microbial and viral infection.  
• Development and validation of FTIR spectroscopic method for the quantification of pharmaceuticals.